Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1997 | 09-1997 | 06-1997 | 03-1997 | 12-1996 | |
| Sales | 991 | 396 | 646 | 569 | 759 |
| Cost of Goods | 440 | 1,127 | 1,006 | 1,006 | 1,084 |
| Gross Profit | 540 | -480 | -438 | -220 | -496 |
| Operating Expenses | 940 | 127 | 6 | 6 | 84 |
| Operating Income | 51 | -731 | -360 | -437 | -325 |
| Interest Expense | 10 | 19 | 17 | 17 | 40 |
| Other Income | 29 | 317 | -34 | 43 | 181 |
| Pre-tax Income | 70 | -433 | -412 | -412 | -185 |
| Income Tax | 0 | 14 | 22 | 22 | N/A |
| Net Income Continuous | 73 | -574 | -401 | -398 | -298 |
| Net Income | $73 | $-574 | $-401 | $-398 | $-298 |
| EPS Basic Total Ops | 0.01 | -0.10 | -0.07 | -0.07 | -0.05 |
| EPS Basic Continuous Ops | 0.01 | -0.10 | -0.07 | -0.07 | -0.05 |
| EPS Diluted Total Ops | 0.01 | -0.10 | -0.07 | -0.07 | -0.05 |
| EPS Diluted Continuous Ops | 0.01 | -0.10 | -0.07 | -0.07 | -0.05 |
| EBITDA(a) | $51 | $-731 | $-360 | $-437 | $-325 |